Horowitz: CDC issues alert for child hepatitis, but will we discover the cause?



One after another, we are seeing mysterious illnesses pop up throughout the world, with many young people either dying or getting ill suddenly. Over the past year and a half, we have injected half of all humanity with multiple doses of a dangerous mRNA gene therapy that has already clearly caused numerous neurological, hematological, and cardiac illnesses, and there are over 1,000 others observed by Pfizer in the first few months of the rollout. Yet the government agencies are taking a “see no evil, hear no evil” approach and won’t even investigate the shots as a potential cause of any of these maladies.

The latest craze in the media is the sudden occurrence of severe hepatitis among young children in the U.S. and several European countries. After several weeks of media reports across both continents of mysterious outbreaks of pediatric hepatitis, the CDC issued an alert last Thursday asking pediatricians to be on the lookout for hepatitis, which is liver inflammation, often expressed symptomatically with jaundice and gastroenterological problems.

There have been nine cases of hepatitis in children in Alabama and two in North Carolina, several of whom needed liver transplants. The CDC, in its statement, seems to have eliminated COVID or the typical hepatitis viruses that cause the inflammation as a culprit. However, the agency appears to be focusing its investigation on adenovirus as a potential cause, because it claims some of the kids were infected with adenovirus type 41.

However, while this concern should not be ruled out, notice what is never ruled in? The inflammatory gene therapy that was just introduced to the entire population. Adenoviruses are almost as common and as mild as rhinoviruses in children, and we’ve never experienced this problem before. Why would adenovirus suddenly become pro-inflammatory in the liver without any other confounding factors? Why wouldn’t we look at the brand-new product that is known to cause inflammation and produce auto-antibodies in numerous parts of the body, but most prominently in the liver, where the highest concentration of the lipid nanoparticles is deposited?

While the CDC is correct that inflammation of the liver “can be caused by viral infections, alcohol use, toxins, medications, and certain other medical conditions,” it is missing one major cause: autoimmune hepatitis. Here’s why, at a minimum, you’d want to investigate the shots as a potential culprit or contributing factor:

1) We know that the shots seem to trigger an uncontrolled antibody response all over the body, with the mRNA coding the tissue to produce spike proteins throughout the body. The spike protein triggers the inflammatory auto-antibody response throughout the body, but is carried most prominently to the liver. The Canadian bio-distribution table (p. 23) shows that the Pfizer shot’s lipid nanoparticles are deposited in the liver more than anywhere else after the injection site itself.

After just 48 hours, roughly 16% of the 50-microgram dose was deposited in the liver. Several months ago, researchers at Thomas Jefferson University found that the lipid nanoparticles used in the mRNA vaccines were hyper-inflammatory in mice. “The mRNA-LNP platforms' potency in supporting the induction of adaptive immune responses and the observed side effects may stem from the LNPs' highly inflammatory nature,” concluded the paper, published in Science Direct.

2) The European Medicines Agency has an assessment of the animal trials on Comirnaty and found (p. 49) liver inflammation in some rats:

If you trace the areas of inflammatory responses in the rates, they coincide with the areas that received a substantial deposit of lipid nanoparticles, such as the bone marrow, spleen, and lymph nodes.

3) In February, a bombshell study was published in Sweden the showed that in vitro, Pfizer mRNA vaccines use a reverse transcriptase enzyme called LINE-1 to potentially reverse-transcribe the genetic code of the vaccine into the DNA. Guess which cell tissues were used in that study? Liver cells! “In the BNT162b2 toxicity report, no genotoxicity nor carcinogenicity studies have been provided,” observed the authors. “Our study shows that BNT162b2 can be reverse transcribed to DNA in liver cell line Huh7, and this may give rise to the concern if BNT162b2-derived DNA may be integrated into the host genome and affect the integrity of genomic DNA, which may potentially mediate genotoxic side effects.”

Given what we know about reverse transcription and the concentration of the vaccine depositing in the liver, how could we rule out the vaccine as the cause of liver inflammation?

4) Last year, Dutch researchers posted an observational study of an 82-year old patient who they believe suffered a reactivation of hepatitis C infection after receiving the Pfizer shot, which “manifested with jaundice, loss of consciousness, hepatic coma and death.” A number of acute hepatitis injury cases have been recorded in VAERS and linked back to the shots.

of Hepatitis from the CDC Wonder Data Base\n\nNot exhaustive, just what I have tweeted thus farhttps://twitter.com/JeanRees10/status/1457170848486416385\u00a0\u2026
— Jean Rees (@Jean Rees) 1650161397

The bottom line is that we are seeing epidemics of autoimmune diseases pop up everywhere. Every doctor I’ve consulted on the issue of COVID treatment and vaccine injury attests to a sudden, unnatural spike in Epstein-Barr virus (the virus that causes mononucleosis) and shingles, two autoimmune diseases believed to be triggered by the shots. It doesn’t mean that every sudden mysterious ailment is caused by the shots, but what it does mean is that the medical community will never have interest in even investigating the shots as a contributing factor.

Earlier this year, an Israeli Health Ministry survey found that roughly 24% of people with pre-existing autoimmune disorders reported a worsening or reactivation of their condition after taking a Pfizer booster. There is no doubt that the shots are triggering certain autoimmune disorders. We also know that autoimmune hepatitis exists and certain auto-antibodies can inflame the liver and attack liver cells. When in history have we ever liberally handed out a shot that triggers an uncontrolled antibody response throughout the body to a very pro-inflammatory spike protein that happens to be deposited in the liver?

Just as with the uncanny explanations for youngsters suddenly getting strokes and heart attacks, it will at least be grimly amusing to watch the array of theories presented for the sudden spike in liver inflammation.

Horowitz: What did Pfizer know and when? 3 important findings from recent document releases



It’s no longer January 2021, when we all thought we lived in a world of normal vaccines. It’s no longer OK for elected officials to mindlessly repeat the bromide “safe and effective” without any reflection about the mass injury we’ve witnessed, along with the waning and the negative efficacy, in itself, engendering calls for endless boosters. We have so much information that raises serious questions, not the least of which is from Pfizer’s own documents, now ordered released by a federal judge, thanks to Public Health and Medical Professionals for Transparency, and FOIA requests from groups like the Informed Consent Action Network.

Here are just three of the most recent revelations from these documents that expose the government/pharma narrative to be a lie at its core:

1) Pfizer needed massive staff to process adverse event reports

Several months ago, the FDA released a Pfizer document on adverse events revealing that there were 42,086 adverse events voluntarily reported to the company, of which 1,223 were fatalities, just as of Feb. 28, 2021. A new unredacted copy of that document, which details nine pages of several thousand known categories of adverse effects, reveals the massive scope of injuries that were being reported to Pfizer and raises questions about what company personnel knew, when they knew it, and what they observed in the ensuing months.

In the document, Pfizer reveals that “due to the large numbers of spontaneous adverse event reports,” staff were forced to prioritize “the processing of serious adverse events” and the company had to hire large numbers of staff. “To date, Pfizer has onboarded approximately 600 additional fulltime employees (FTEs),” reveals Pfizer on page six of the confidential document. “More are joining each month with an expected total of more than 1,800 additional resources by the end of June 2021.”

Read this paragraph and ask yourself how many people would have taken the shot had they known this and how the failure to disclose this information is in line with the Nuremberg Code. Also, what is the epilogue of the story? What did Pfizer discover in the ensuing months – to this very day – that it is not disclosing to the public?

2) Rate of myocarditis

When it became apparent to the public earlier in 2021 that myocarditis was a known side effect of the shots, the government and the media immediately claimed the incidence rate was exceedingly low. Numerous “studies” tried to downplay the risks. One paper from Kaiser Permanente in JAMA suggested the rate was just 6.6 per million. Another JAMA study from last June found a 1 in 50,000 rate among the military (which we now know was woefully underreported). Well, thanks to ICAN’s FOIA, we now have the Pfizer informed consent document (p. 5) that shows the company recognized the risk can be as high as 1 in 1,000.

So, all of these stories suggesting that young males were more at risk for myocarditis from the virus than from the shots were bogus, and Pfizer knew it. And again, if this is the degree the company is willing to concede, imagine what the true incidence rate is.

Also, what is the degree of subclinical myocarditis? If we know about this many cases shortly after the injection, who’s to say there isn’t another cohort of people with heart damage that has remained subclinical so far but could come to fruition several months later? Remember, with many fewer vaccines administered in 2022, the rate of myocarditis reports to VAERS is averaging 245% higher than last year.

Is this the glimpse into the long-term effects of those who originally had subclinical myocarditis last year, and is this one of the reasons why so many athletes continue to drop?

The FDA has made it clear that it is flying blind on subclinical myocarditis and long-term heart damage. In the Pharmacovigilance Plan Review Addendum for Comirnaty, the FDA conceded (p. 3-4), “Incidence of subclinical myocarditis and potential long-term sequelae following COMIRNATY are unknown.” However, they did note that a previous study on a smallpox vaccine “suggested an incidence of possible subclinical myocarditis (based on cardiac troponin T elevations) 60-times higher than the incidence rate of overt clinical myocarditis.” That would bring down the 1 in 1,000 rate among young males to as low as 1 in 17 for subclinical ticking time bombs!

Why has the government not studied troponin levels of those who got the shot? Why has it not conducted cardiac MRIs to check for scarring? Why are we flying blind over a year into the known myocarditis problems?

The FDA reviewers flatly stated, “Based on review of available data, there are known risks for myocarditis and pericarditis and an unexpected serious risk for subclinical myocarditis, which warrant PMR safety studies to assess these serious risks.” They called on Comirnaty (PfizerBionTech) to conduct studies, but noted that the sponsor rebuffed them. Seven and a half months after their full approval, we still have no studies, and they are due to be complete July 2023!

So looking at the Clinical Study, here is the description.\nThe study is not due to be completed until July 2023.pic.twitter.com/C16sAjzc9X
— Jean Rees (@Jean Rees) 1648394844

3) Pfizer knew about natural immunity

Pfizer never studied the efficacy of the shots exclusively among those with prior infection. Bizarrely, a new document reveals researchers studied them together; however, they break down the results in a way that reveals no need for the shots among those with prior infection. Here is the money quote from p. 12 of Pfizer’s “request for priority review” in May 2021:

Among participants without evidence of SARS-CoV-2 infection before and during the vaccination regimen (evaluable efficacy population), the estimated VE against FDA-defined severe COVID-19 (protocol definition) occurring at least 7 days after Dose 2 was 95.3% (2-sided 95% CI: 71.0%, 99.9%), with 1 and 21 cases in the BNT162b2 and placebo groups, respectively. Similarly, the estimated VE was also 95.3% (2-sided 95% CI: 70.9%, 99.9%) among participants with or without evidence of SARS-CoV-2 infection, also with 1 and 21 cases in the BNT162b2 and placebo groups, respectively.

Pfizer claims efficacy against severe illness among those who took the shot vs. the placebo group among those without prior infection. Researchers report one case in the trial group and 21 in the placebo group. Then they mix together results of those with and without prior infection, and yet the numbers remain the same at 1 and 21 respectively! That means that among those with prior infection, there were zero cases of serious reinfection in both the trial and placebo groups. They might call that 100% effective, but we can also call that 0% effective. Thus, they knew people didn’t need the shot if they already had prior infection, but they promoted it anyway and still got approval.

This is just the tip of the iceberg. In the coming days, more information will come out about what Pfizer knew and when. The question is will any policies change as a result.

On a final note: At least Pfizer is being forced to release some documents. How come we don’t have a single document from Moderna, which is an even stronger dose? Inquiring minds would like to know.